Unibest
← Back to patent-cliff list

Bupivacaine

Tier C — Watch / trade

Bupivacaine

Cellix Bio Pvt Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Sodium channels

Brand:BupiZenge

Indications (approved):Subacromial impingement syndrome, Postoperative pain

Regional status

US
Approved
EU
Phase III
2026-07-07
China
-
Japan
-

Factories producing this API2

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

2 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates3 routes

Originator routes × 0Optimised (non-patent) × 3Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 3 · Total yield /
(I)91311-1-a535-75-1(II)91311-1-a71170-88-2(III)91311-1-a87-62-7(IV)91311-1-a—(V)91311-1-a15883-20-2(VI)91311-1-a109-65-9API · Bupivacaine
CodeCAS No.Intermediate
(I)91311-1-a535-75-1(+/-)-Piperidine-2-carboxylic acid
(II)91311-1-a71170-88-21-[(Benzyloxy)carbonyl]piperidine-2-carboxylic acid
(III)91311-1-a87-62-7Available2-Amino-1,3-dimethylbenzene
(IV)91311-1-a-Phenyl 2-[(2,6-dimethylphenyl)carbamoyl]piperidine-1-carboxylate
(V)91311-1-a15883-20-2Available(RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide
(VI)91311-1-a109-65-91-Bromobutane
OptimisedRoute 2Steps 4 · Total yield /
(I)91311-2-a535-75-1(II)91311-2-a15862-86-9(III)91311-2-a36293-02-4(IV)91311-2-a87-62-7(V)91311-2-a15883-20-2(VI)91311-2-a109-65-9API · Bupivacaine
CodeCAS No.Intermediate
(I)91311-2-a535-75-1(+/-)-Piperidine-2-carboxylic acid
(II)91311-2-a15862-86-9DL-Pipecolic acid hydrochloride
(III)91311-2-a36293-02-4Piperidine-2-carbonyl chloride hydrogen chloride
(IV)91311-2-a87-62-7Available2-Amino-1,3-dimethylbenzene
(V)91311-2-a15883-20-2Available(RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide
(VI)91311-2-a109-65-91-Bromobutane
OptimisedRoute 3Steps 1 · Total yield /
(I)91311-3-a87-62-7(II)91311-3-a—(III)91311-3-a—API · Bupivacaine
CodeCAS No.Intermediate
(I)91311-3-a87-62-7Available2-Amino-1,3-dimethylbenzene
(II)91311-3-a-1-Butylpiperidine-2-carbaldehyde
(III)91311-3-a-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

Frequently asked questions

What are the approved indications of Bupivacaine?

Approved indications include: Subacromial impingement syndrome, Postoperative pain.

When does the Bupivacaine patent expire?

No public expiry year is available for Bupivacaine yet; this page updates once verified.

How many synthesis routes are recorded for Bupivacaine?

3 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Bupivacaine intermediates?

2 intermediate CAS of Bupivacaine are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Bupivacaine intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29